SCHEMBL6701265

SCHEMBL6701265

CC(C(=O)Nc1ccccc1Cc1ccccc1C(=O)O)c1ccc(C(=O)c2cccs2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.56
HPGD P15428 4/20 0.54
PTGS1 P23219 4/20 0.54
PTGS2 P35354 4/20 0.54
ALDH1A1 P00352 4/20 0.54
CYP2C9 P11712 3/20 0.54
LMNA P02545 2/20 0.54
KDM4E B2RXH2 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
MAPT P10636 3/20 0.43
ALOX15 P16050 1/20 0.43
HPGDS O60760 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700849 0.88 PTGER4 (0.64) PTGER4HPGDALDH1A1CYP2C9LMNA
SCHEMBL5350278 0.81 PTGER4 (0.64) PTGER4PTGS2LMNAMAPTL3MBTL1
SCHEMBL5358711 0.80 MAPT (0.63) PTGER4PTGS1PTGS2CYP2C9LMNA
SCHEMBL5346187 0.78 PTGER4 (0.60) PTGER4ALDH1A1CYP2C9LMNAMAPT
SCHEMBL5365542 0.78 PTGER4 (0.60) PTGER4ALDH1A1LMNAKDM4EMAPT
SCHEMBL6701289 0.76 PTGER4 (0.58) PTGER4LMNAKDM4EMAPTL3MBTL1
SCHEMBL5350288 0.76 PTGER4 (0.66) PTGER4HPGDCYP2C9LMNAKDM4E
SCHEMBL13880085 0.76 HPGD (0.72) HPGDPTGS1PTGS2ALDH1A1CYP2C9
SCHEMBL5352027 0.75 PTGER4 (0.56) PTGER4LMNAL3MBTL1RAB9ANPC1
SCHEMBL5347447 0.75 PTGER4 (0.56) PTGER4MAPTL3MBTL1RAB9ACRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US claimed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP claimed
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US disclosed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient PTGER1, PTGER4, PTGES PTGER4 2/4885HPGD 141/4885PTGS1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.